Characterisation of the RNA editing functions of A3B in human cancers has remained a challenge primarily due to interference from the genomic DNA cytidine deamination activity of A3B [6] and, depending on the cellular context, background RNA editing from other APOBEC3 family members - most notably A3A [7, 45]. Here, APOBEC3A is linked to cancer.